Topical Insulin for Postoperative Wound Healing
Status
Conditions
Treatments
Details and patient eligibility
About
This study aimed to investigate the potential effect of applying topical insulin therapy on the management and healing of postoperative wounds in patients known with type 2 diabetes mellitus (T2DM) and in a parallel group without diabetes. Investigators also studied the effect of topical insulin therapy on the expression of e-cadherin and Ki67, as markers for cellular proliferation and wound repair. The levels of IL-6 and the H2O2-induced DNA damage product, 8-hydroxy-2'-deoxyguanosine (8-OHdG), were assessed as markers for inflammation and oxidative stress. Finally, histomorphological assessment of skin biopsies was also carried out.
Full description
The study participants will be recruited from general surgery department ,all patients with elective surgical procedure who will be admitted at the department for at least one week as it is the minimal duration of postoperative wound healing and the study will be conducted according to the regulations of ethical committee of clinical studies in the Faculty of Medicine, Cairo University
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Both males and females
- 40-60 years old
- diagnosed with type 2 DM (for the diabetic trial)
- For the diabetic trial: glycosylated hemoglobin (HBA1c) ≤7.5 %
- haemoglobin (Hb) ≥ 12 g/dl
- Patients who had a full thickness post-operative wound of ≥10 cm
Exclusion criteria
- Those with known history of immunodeficiency, keloid formation, or hyperkeratotic skin lesion.
- Patients who had hypersensitivity to insulin,
- Patients with severe infection,
- Patients with any severe organ dysfunction
- Patients who were admitted to ICU
Trial design
Primary purpose
Allocation
Interventional model
Masking
74 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal